Datasets

3 datasets

Format: HTML Tag: antiretroviral-therapy Clear all

HealthData.Gov

Continuing HIV therapy in the ICU

The risks and benefits of stopping antiretroviral therapy in patients admitted to the ICU are largely unmeasured. In many cases therapy has to be stopped, as parenteral preparations are unavailable for all but one of…

HTML

Updated Oct 29, 2026

HealthData.Gov

Hepatic adverse events during highly active antiretroviral therapy containing nevirapine: a case report

Background Hepatotoxicity is one of the most serious complications of highly active antiretroviral therapy (HAART). The aim of this report is to analyse an HIV infected patient on HAART including nevirapine and taking…

HTML

Updated Oct 29, 2026

HealthData.Gov

Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C

Background The standard of care for HCV Hepatitis is the combination of interferon (IFN) plus Ribavirin. In HIV patients the use of this combination therapy may induce drug interactions, and reduces the adherence to…

HTML

Updated Oct 29, 2026